首页> 外文期刊>Mutation Research: International Journal on Mutagenesis, Chromosome Breakage and Related Subjects >Frequent retention of heterozygosity for point mutations in p53 and Ikaros in N-ethyl-N-nitrosourea-induced mouse thymic lymphomas.
【24h】

Frequent retention of heterozygosity for point mutations in p53 and Ikaros in N-ethyl-N-nitrosourea-induced mouse thymic lymphomas.

机译:在N-乙基-N-亚硝基脲诱导的小鼠胸腺淋巴瘤中,p53和Ikaros中点突变的杂合性经常保留。

获取原文
获取原文并翻译 | 示例
           

摘要

In agreement with Knudson's two-hit theory, recent findings indicate that the inactivation of tumor suppressor genes is not only mediated by the loss of function but also by the dominant-negative or gain-of-function activity. The former generally accompanies loss of a wild-type allele whereas in the latter a wild-type allele is retained. N-Ethyl-N-nitrosourea (ENU), which efficiently induces point mutations, reportedly leads to the development of tumors by activating ras oncogenes. Little is known about how ENU affects tumor suppressor genes and, therefore, we examined ENU-induced mutations of p53 and Ikaros in thymic lymphomas and compared these with mutations of Kras. In addition, loss of heterozygosity was examined for chromosome 11 to which both p53 and Ikaros were mapped. The frequency of point mutations in p53 and Ikaros was 30% (8/27) and 19% (5/27), respectively, comparable to that observed in Kras (33%: 9/27). In total, 14 of the 27 thymic lymphomas examined (52%) harbored mutations in at least one of these genes. One Ikaros mutation was located at the splice donor site, generating a novel splice isoform lacking zinc finger 3, Ik (F3del). Interestingly, 90% (10/11) of the tumors with point mutations retained wild-type alleles of p53 and Ikaros. Sequence analysis revealed that the most common nucleic acid substitutions were T>A (4/8) in p53, T>C (4/5) in Ikaros and G>A/T (8/9) in Kras, suggesting that the spectrum of mutations was gene dependent. These results suggest that point mutations in tumor suppressor genes without loss of the wild-type allele play an important role in ENU-induced lymphomagenesis.
机译:与克努森的两次打击理论相一致,最近的发现表明,抑癌基因的失活不仅由功能丧失介导,而且由显性负或功能获得活性介导。前者通常伴随着野生型等位基因的丢失,而后者则保留了野生型等位基因。据报道,有效诱导点突变的N-乙基-N-亚硝基脲(ENU)通过激活ras癌基因导致肿瘤的发展。关于ENU如何影响肿瘤抑制基因知之甚少,因此,我们检查了ENU诱导的胸腺淋巴瘤中p53和Ikaros的突变,并将其与Kras突变进行了比较。此外,检查了p53和Ikaros都定位到的11号染色体的杂合性丧失。在p53和Ikaros中点突变的频率分别为30%(8/27)和19%(5/27),与在Kras中观察到的频率相同(33%:9/27)。总共检查的27种胸腺淋巴瘤中,有14种(52%)至少具有这些基因之一的突变。一个Ikaros突变位于剪接供体位点,产生了缺乏锌指3 Ik(F3del)的新型剪接同工型。有趣的是,有点突变的肿瘤中有90%(10/11)保留了p53和Ikaros的野生型等位基因。序列分析显示,最常见的核酸替换是p53中的T> A(4/8),Ikaros中的T> C(4/5)和Kras中的G> A / T(8/9),这表明该光谱突变是基因依赖性的。这些结果表明,在不丢失野生型等位基因的情况下,肿瘤抑制基因中的点突变在ENU诱导的淋巴瘤发生中起重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号